Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
28.27
+2.62 (10.21%)
At close: May 8, 2026, 4:00 PM EDT
29.09
+0.82 (2.90%)
After-hours: May 8, 2026, 7:59 PM EDT
Hims & Hers Health Revenue
In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth. Hims & Hers Health had revenue of $617.82M in the quarter ending December 31, 2025, with 28.41% growth.
Revenue (ttm)
$2.35B
Revenue Growth
+59.00%
P/S Ratio
2.78
Revenue / Employee
$961,358
Employees
2,442
Market Cap
6.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.35B | 871.13M | 59.00% |
| Dec 31, 2024 | 1.48B | 604.51M | 69.32% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.89B |
| Dr. Reddy's Laboratories | 3.85B |
| Neurocrine Biosciences | 3.10B |
| Amneal Pharmaceuticals | 3.05B |
| Alkermes | 1.56B |
| Lantheus Holdings | 1.55B |
| Prestige Consumer Healthcare | 1.10B |
| Supernus Pharmaceuticals | 776.83M |
HIMS News
- 2 days ago - Polymarket Earnings: Will HIMS, CRCL, QUBT Beat Earnings on Monday? - TipRanks
- 2 days ago - HIMS Stock Options Traders Are Pricing In a Huge Price Swing after Earnings - TipRanks
- 2 days ago - Hims & Hers (HIMS) Set to Report Q1 Earnings — Here’s What Analysts Expect - TipRanks
- 3 days ago - 7 stocks expecting a post-earnings jolt — including Applied Materials and Cisco Systems - Market Watch
- 3 days ago - Mixed options sentiment in Hims and Hers Health with shares down 3.44% - TheFly
- 6 days ago - Moderately bullish activity in Hims and Hers Health with shares down 1.2% - TheFly
- 12 days ago - Mixed options sentiment in Hims and Hers Health with shares down 4.95% - TheFly
- 12 days ago - Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors - Business Wire